Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	460.48	398.2	214.2	140.83	119.07	102.31
Revenue Growth (YoY)	32.17%	85.90%	52.10%	18.27%	16.39%	20361.20%
Cost of Revenue	73.83	145.12	54.18	38.82	33.54	33.6
Gross Profit	386.65	253.09	160.02	102.01	85.54	68.7
Selling, General & Admin	175.58	133.71	57.09	49.63	44.23	36.88
Operating Expenses	212.68	166.28	58.18	49.63	44.23	36.88
Operating Income	173.97	86.81	101.84	52.39	41.3	31.82
Interest & Investment Income	12.87	4.68	3.64	0.28	0.59	1.59
EBT Excluding Unusual Items	186.84	91.49	105.48	52.67	41.89	33.41
Gain (Loss) on Sale of Investments	1.95	3.02	-0.76	-	-	-
Pretax Income	188.79	94.51	104.72	52.67	41.89	33.41
Income Tax Expense	45.99	23.1	21.64	13.19	-33.09	1.53
Net Income	142.8	71.41	83.08	39.48	74.98	31.88
Net Income to Common	142.8	71.41	83.08	39.48	74.98	31.88
Net Income Growth	130.18%	-14.05%	110.42%	-47.35%	135.24%	-
Shares Outstanding (Basic)	115	106	103	103	104	103
Shares Outstanding (Diluted)	122	114	111	108	106	106
Shares Change (YoY)	6.94%	2.13%	3.32%	1.46%	0.21%	3.30%
EPS (Basic)	1.24	0.67	0.80	0.38	0.72	0.31
EPS (Diluted)	1.18	0.63	0.75	0.37	0.71	0.30
EPS Growth	114.68%	-16.00%	102.70%	-47.89%	136.67%	-
Free Cash Flow	188.02	-54.92	106.02	59.35	45.02	34.59
Free Cash Flow Per Share	1.54	-0.48	0.95	0.55	0.42	0.33
Gross Margin	83.97%	63.56%	74.71%	72.44%	71.84%	67.16%
Operating Margin	37.78%	21.80%	47.54%	37.20%	34.69%	31.11%
Profit Margin	31.01%	17.93%	38.79%	28.03%	62.97%	31.16%
Free Cash Flow Margin	40.83%	-13.79%	49.49%	42.14%	37.81%	33.81%
EBITDA	211.43	119.69	103.08	52.58	41.4	31.88
EBITDA Margin	45.92%	30.06%	48.12%	37.33%	34.76%	31.16%
D&A For EBITDA	37.46	32.88	1.24	0.19	0.09	0.06
EBIT	173.97	86.81	101.84	52.39	41.3	31.82
EBIT Margin	37.78%	21.80%	47.54%	37.20%	34.69%	31.11%
Effective Tax Rate	24.36%	24.44%	20.66%	25.03%	-	4.59%
Revenue as Reported	460.48	398.2	214.2	140.83	119.07	102.31
Advertising Expenses	-	9.1	3.3	2.9	2.5	3.3

Source: S&P Capital IQ. Standard template. Financial Sources.